Intestinal permeability evaluation in patients with chronic Chagas heart failure

Angela Braga Rodrigues1, Henrique Oswaldo da Gama Torres2, Maria do Carmo Pereira Nunes1,2

  • 1Postgraduate Course of Infectious Diseases and Tropical Medicine, School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.

ESC Heart Failure
|January 28, 2023
PubMed

Insights

This study found no significant difference in intestinal permeability between chronic Chagas cardiomyopathy patients and healthy controls. Further research is needed for patients with more severe left ventricular ejection fraction (LVEF) reductions.

Area of Science:

  • Cardiology
  • Gastroenterology
  • Infectious Diseases

Background:

  • Intestinal dysfunction may worsen chronic Chagas cardiomyopathy (CCC) outcomes.
  • Understanding gut barrier function is crucial for managing heart failure in CCC patients.

Purpose of the Study:

  • To analyze intestinal permeability in CCC patients.
  • To assess the association between intestinal permeability and clinical factors, echocardiographic parameters, and disease prognosis.
  • To compare intestinal permeability between CCC patients and healthy controls.

Main Methods:

  • Prospective selection of 50 CCC patients with left ventricular ejection fraction (LVEF) <55% and 27 healthy controls.
  • Intestinal permeability assessed using the lactulose/mannitol sugar probe drink test.
  • Urinary recovery of mannitol (monosaccharide) and lactulose (disaccharide) measured over a follow-up period of 18 ± 8 months.

Main Results:

  • No significant difference in the lactulose/mannitol ratio was observed between CCC patients and healthy controls.
  • Intestinal permeability did not correlate with clinical signs of congestion, hemodynamic parameters, or disease severity and outcome.

Conclusions:

  • The study did not detect intestinal barrier disturbances in CCC patients with LVEF <55% via lactulose/mannitol ratio.
  • Further investigation is warranted to determine if intestinal permeability increases in patients with LVEF <40%.
Abstract